We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Zinc Reduces Death in Children with Diarrhea

By HospiMedica staff writers
Posted on 21 Nov 2002
A large international study has found that zinc therapy can lower the incidence of diarrhea in children, reduce their rates of hospitalization, and lower their noninjury death rate by 50%. More...
The findings were reported in the November 9, 2002, issue of the British Medical Journal.

The study involved 8,070 Bangladeshi children during episodes of diarrhea. The children who were treated received 20 mg elemental zinc daily for 14 days during each episode of diarrhea in addition to oral rehydration therapy (ORS). The ORS use increased by 20% and antibiotic use decreased by 60% in the zinc clusters.
Despite many advances, diarrheal diseases and the resulting dehydration are still responsible for the deaths of about two million children every year. Most cases occur in developing, resource-poor countries, where children suffer from malnutrition and where access to clean water, safe sanitation, and health facilities are limited. A recent meeting of the World Health Organization (WHO, Geneva, Switzerland) reviewed the findings of this and other zinc trials and concluded that zinc supplements are efficacious in reducing the severity and duration of diarrhea.
"The lower rates of child morbidity and mortality with zinc therapy represent substantial benefits from a simple and inexpensive intervention that can be incorpo-rated within existing diarrheal disease control efforts, which should significantly improve child health and survival,” said Abdullah Baqui, MPH, associate professor, international health, Johns Hopkins Bloomberg School of Public Health Research (Baltimore, MD, USA) and author of the study.



Related Links:
Johns Hopkins

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.